Nxera Pharma Cash from Financing (TTM) Insights

Nxera Pharma Co Ltd (SOLTF)

9.72 0.00 (0.00%) USD | OTCM | Apr 23, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	344.46M
September 30, 2023	271.64M
June 30, 2023	-1.360M
March 31, 2023	-37.47M
December 31, 2022	-37.48M
September 30, 2022	-35.29M
June 30, 2022	60.36M
March 31, 2022	99.12M
December 31, 2021	101.38M
September 30, 2021	96.82M
June 30, 2021	195.48M
March 31, 2021	193.78M
December 31, 2020	189.98M
September 30, 2020	150.28M
June 30, 2020	-50.19M
March 31, 2020	-61.78M
December 31, 2019	-63.90M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018	161.44M
June 30, 2018	156.96M
March 31, 2018	204.35M
December 31, 2017	195.80M

Date	Value
September 30, 2017	20.33M
June 30, 2017	-13.74M
March 31, 2017	-58.35M
December 31, 2016	-50.87M
September 30, 2016	-29.50M
June 30, 2016	2.470M
March 31, 2016	7.192M
December 31, 2015	194.68M
September 30, 2015	168.79M
June 30, 2015	181.35M
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014	43.68M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-63.90M

Minimum

Dec 2019

344.46M

Maximum

Dec 2023

83.28M

Average

96.82M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks